Skip to content

Colorectal Cancer Screening Validation Study

Altered Gene Expression in Colorectal Smears of Individuals With Colon Cancer

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00720993
Acronym
CRC screening
Enrollment
165
Registered
2008-07-23
Start date
2008-08-31
Completion date
2009-05-31
Last updated
2009-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer Screening

Keywords

Colorectal cancer screening, Gene expression, RTPCR

Brief summary

The purpose of this study is to evaluate the gene expression patterns from colorectal mucosal cells collected through the use of a standard anoscope and cytology brush. Patients will include those scheduled for routine colonoscopy procedures and those with confirmed colorectal cancer.

Interventions

None listed

Sponsors

BiotechNiks / Molecular Medicine Research Institute
CollaboratorUNKNOWN
IntelliGeneScan, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* willing to provide informed consent * greater than or equal to 50 years of age * patient is scheduled for routine colonoscopy procedure or colorectal cancer surgery * subject is willing to provide colorectal mucosal sample for gene expression testing

Exclusion criteria

* recent radiation or treatment for gynecologic, prostate or rectal cancer * recent surgery for anal rectal disease * polys, family or self history of cancer (control group only) * GI disease * any mucosal disease or systemic condition that may confound the scientific interpretation of the gene expression results

Design outcomes

Primary

MeasureTime frame
- To select a threshold for Mahalanobis distance to determine the best operating characteristics (sensitivity and specificity) in subjects with cancer and subjects without cancer. - To explore other empirical metrics based on previous exploratory dataMai 2009

Secondary

MeasureTime frame
- To obtain data to estimate sensitivity, specificity, and the ROC curve for a test based on M-distance. - To determine the variability of sensitivity and specificity estimatesMai 2009

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026